|
|
Volumn 264, Issue 5158, 1994, Pages 499-
|
|
NIH tightens clinical trials monitoring
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TAMOXIFEN;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
DRUG APPROVAL;
ENDOMETRIUM TUMOR;
ETHICS;
FEMALE;
HEALTH CARE ORGANIZATION;
HUMAN;
IATROGENIC DISEASE;
MULTIMODALITY CANCER THERAPY;
ORGANIZATION AND MANAGEMENT;
SEGMENTAL MASTECTOMY;
STANDARD;
UNITED STATES;
MONITORING;
PRIORITY JOURNAL;
SHORT SURVEY;
BREAST NEOPLASMS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMAN;
INVESTIGATIONAL NEW DRUG APPLICATION;
MASTECTOMY, SEGMENTAL;
NATIONAL INSTITUTES OF HEALTH (U.S.);
SCIENTIFIC MISCONDUCT;
TAMOXIFEN;
UNITED STATES;
|
|
EID: 0028778491
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.8160006 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|